ODDB.org: Open Drug Database

Co-Amoxi-Mepha 312,5, Pulver zur Herstellung einer Suspension zum Einneh - 100 ml

Swissmedic Key	53982002	Registration Holder	Mepha Pharma AG
Name	Co-Amoxi-Mepha 312,5, Pulver zur Herstellung einer Suspension zum Einneh	Date of registration	10.03.2000
Original/Generic	Generic	Introduction of Sequence	10.03.2000
ATC-Classification	Amoxicillin and Beta-Lactamase Inhibitor (J01CR02)	Revision date	23.08.2006
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	08.01.93.	Show package size	100 ml
Index Therapeuticus (Swissmedic)	08.01.93.	Description
Swissmedic categorie.	A
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information	CI
Ex-factory-Price	11.35	Limitation	No

Deductible	10 %	Consumer price	25.35
Feedback	FB
GTIN	7680539820022	Medication Code	Synthetika
Pharmacode		Disponibility

Composition

amoxicillinum anhydricum 250 mg ut amoxicillinum trihydricum, acidum clavulanicum 62.5 mg ut kalii clavulanas, silica colloidalis anhydrica, xanthani gummi, crospovidonum, carmellosum natricum, aspartamum 16.64 mg, aromatica (Erdbeer) cum alcohol benzylicus et propylenglycolum, ad pulverem corresp. suspensio reconstituta 5 ml corresp. natrium max. 4.7 mg.

Packungsbestandteile

Galenic Form

Pulver zur Herstellung einer Suspension zum Einneh

Excipiens

Active Agent	Dose
Clavulanic Acid	62.5 mg
Amoxicillin Anhydride	250 mg

BAG: Active Agent	Dose
Clavulanic Acid	62.5 mg
Amoxicillin Anhydride	250 mg

Inactive agents	Dose
Aromatica (Erdbeer) cum Alcohol Benzylicus
Aspartame	16.64 mg
Carmellose Sodium
Crospovidonum
Propylenglycol
Silica Colloidalis Anhydrica
Xanthani Gummi

Source

Data was imported : 06.07.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2024	©ywesee GmbH